Modulation of muscle contraction by a cell-permeable peptide

被引:0
|
作者
Gisela Tünnemann
Peter Karczewski
Hannelore Haase
M. Cristina Cardoso
Ingo Morano
机构
[1] Max Delbrück Center for Molecular Medicine,Charité Medical School
[2] Johannes Müller Institute for Physiology,undefined
来源
关键词
Ventricular light chain-1 (VLC-1); Cell penetrating peptide (CPP); Peptide transduction; Cardiomyocytes; Drug delivery;
D O I
暂无
中图分类号
学科分类号
摘要
In contrast to immortal cell lines, primary cells are hardly susceptible to intracellular delivery methods such as transfection. In this study, we evaluated the direct delivery of several cell-permeable peptides under noninvasive conditions into living primary adult rat cardiomyocytes. We specifically monitored the functional effects of a cell-permeable peptide containing the 15 amino acid N-terminal peptide from human ventricular light chain-1 (VLC-1) on contraction and intracellular Ca2+ signals after electrical stimulation in primary adult cardiomyocytes. The transducible VLC-1 variant was taken up by cardiomyocytes within 5 min with more than 95% efficiency and localized to sarcomeric structures. Analysis of the functional effects of the cell-permeable VLC-1 revealed an enhancement of the intrinsic contractility of cardiomyocytes without affecting the intracellular Ca2+. Therefore, peptide transduction mediated by cell-penetrating peptides represents not only a unique strategy to enhance heart muscle function with no secondary effect on intracellular Ca2+ but also an invaluable tool for the modulation and manipulation of protein interactions in general and in primary cells.
引用
收藏
页码:1405 / 1412
页数:7
相关论文
共 50 条
  • [1] Modulation of muscle contraction by a cell-permeable peptide
    Tuennemann, Gisela
    Karczewski, Peter
    Haase, Hannelore
    Cardoso, M. Cristina
    Morano, Ingo
    JOURNAL OF MOLECULAR MEDICINE-JMM, 2007, 85 (12): : 1405 - 1412
  • [2] Cell-permeable, mitochondrial-targeted, peptide antioxidants
    Szeto, Hazel H.
    AAPS JOURNAL, 2006, 8 (02): : E277 - E283
  • [3] Cell-permeable, mitochondrial-targeted, peptide antioxidants
    Hazel H. Szeto
    The AAPS Journal, 2006, 8
  • [4] Conformational and topological requirements of cell-permeable peptide function
    Du, CG
    Yao, SY
    Rojas, M
    Lin, YZ
    JOURNAL OF PEPTIDE RESEARCH, 1998, 51 (03): : 235 - 243
  • [5] Targeting cancer stem cell pathways with cell-permeable peptide inhibitors
    Arndt, Verena
    Friebe, Annette
    Meuser, Elena
    Ross, Katharina
    Agerer, Franziska
    Schulten-Schulz, Carmen
    Waak, Jens
    Friedrich, Daniel
    Hennemann, Hanjo
    Vollmer, Joerg
    CANCER RESEARCH, 2015, 75
  • [6] A cell-permeable peptide inhibits activation of PKR and enhances cell proliferation
    Nekhai, S
    Bottaro, DP
    Woldehawariat, G
    Spellerberg, A
    Petryshyn, R
    PEPTIDES, 2000, 21 (10) : 1449 - 1456
  • [7] Cell-permeable peptide inhibitors of JNK novel blockers of β-cell death
    Bonny, C
    Oberson, A
    Negri, S
    Sauser, C
    Schorderet, DF
    DIABETES, 2001, 50 (01) : 77 - 82
  • [8] Cell-Permeable Bicyclic Peptide Inhibitors against Intracellular Proteins
    Lian, Wenlong
    Jiang, Bisheng
    Qian, Ziqing
    Pei, Dehua
    JOURNAL OF THE AMERICAN CHEMICAL SOCIETY, 2014, 136 (28) : 9830 - 9833
  • [9] Cell-permeable molecules
    Edwards, P
    DRUG DISCOVERY TODAY, 2001, 6 (13) : 701 - 702
  • [10] Inhibition of excitatory neuronal cell death by cell-permeable calcineurin autoinhibitory peptide
    Terada, H
    Matsushita, M
    Lu, YF
    Shirai, T
    Li, ST
    Tomizawa, K
    Moriwaki, A
    Nishio, S
    Date, I
    Ohmoto, T
    Matsui, H
    JOURNAL OF NEUROCHEMISTRY, 2003, 87 (05) : 1145 - 1151